Clinical Trial Update: Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes [Phase 1]

View source ↗

Summary

A Phase 1 study sponsored by Loyola University evaluating adoptive T cell immunotherapy using engineered lymphocytes for advanced melanoma; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Adoptive T cell immunotherapy using engineered lymphocytes (engineered T cells)

Snippet

Sponsor: Loyola University | Conditions: Melanoma | Phase 1 | Status: RECRUITING